These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 31626230)

  • 41. Clinical Utility and Implementation of Pharmacogenomics for the Personalisation of Antipsychotic Treatments.
    Hernandez M; Cullell N; Cendros M; Serra-Llovich A; Arranz MJ
    Pharmaceutics; 2024 Feb; 16(2):. PubMed ID: 38399298
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Personalized medicine in psychiatry: nightmare of the industry?].
    Lazary J; Elemery M; Csala I; Faludi G
    Neuropsychopharmacol Hung; 2016 Sep; 18(3):137-142. PubMed ID: 27824309
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacogenomics: A focus on antidepressants and atypical antipsychotics.
    Lister JF
    Ment Health Clin; 2016 Jan; 6(1):48-53. PubMed ID: 29955447
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A New Intervention for Implementation of Pharmacogenetics in Psychiatry: A Description of the PSY-PGx Clinical Study.
    Pelgrim TAD; Philipsen A; Young AH; Juruena M; Jimenez E; Vieta E; Jukić M; Van der Eycken E; Heilbronner U; Moldovan R; Kas MJH; Jagesar RR; Nöthen MM; Hoffmann P; Shomron N; Kilarski LL; van Amelsvoort T; Campforts B; The Psy-PGx Consortium ; van Westrhenen R
    Pharmaceuticals (Basel); 2024 Jan; 17(2):. PubMed ID: 38399366
    [No Abstract]   [Full Text] [Related]  

  • 45. Using a pharmacogenetic clinical decision support system to improve psychopharmacotherapy dosing in patients with affective disorders.
    Zastrozhin M; Skryabin V; Sorokin A; Buzik O; Bedina I; Grishina E; Ryzhikova K; Shipitsyn V; Bryun E; Sychev D
    Drug Metab Pers Ther; 2020 Sep; 35(4):. PubMed ID: 32870807
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Medical education in pharmacogenomics-results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx).
    Just KS; Steffens M; Swen JJ; Patrinos GP; Guchelaar HJ; Stingl JC
    Eur J Clin Pharmacol; 2017 Oct; 73(10):1247-1252. PubMed ID: 28669097
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19.
    de Leon J; Armstrong SC; Cozza KL
    Psychosomatics; 2006; 47(1):75-85. PubMed ID: 16384813
    [TBL] [Abstract][Full Text] [Related]  

  • 48. AmpliChip CYP450 test: personalized medicine has arrived in psychiatry.
    de Leon J
    Expert Rev Mol Diagn; 2006 May; 6(3):277-86. PubMed ID: 16706732
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The founding of neurology as a specialty: The American situation in context.
    Koehler PJ
    J Hist Neurosci; 2018; 27(3):283-291. PubMed ID: 30118412
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacogenetic research activity in Central America and the Caribbean: a systematic review.
    Céspedes-Garro C; Naranjo MG; Rodrigues-Soares F; LLerena A; Duconge J; Montané-Jaime LK; Roblejo H; Fariñas H; Campos ML; Ramírez R; Serrano V; Villagrán CI; Peñas-LLedó EM
    Pharmacogenomics; 2016 Oct; 17(15):1707-1724. PubMed ID: 27633613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Strengths and weaknesses of pharmacogenetic studies of antipsychotic drugs: the potential value of the PEPs study.
    Mas S; Llerena A; Saíz J; Bernardo M; Lafuente A
    Pharmacogenomics; 2012 Nov; 13(15):1773-82. PubMed ID: 23171340
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ubiquitous Pharmacogenomics (U-PGx): The Time for Implementation is Now. An Horizon2020 Program to Drive Pharmacogenomics into Clinical Practice.
    Cecchin E; Roncato R; Guchelaar HJ; Toffoli G;
    Curr Pharm Biotechnol; 2017; 18(3):204-209. PubMed ID: 28044932
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacogenetics in Latin American populations: regulatory aspects, application to herbal medicine, cardiovascular and psychiatric disorders.
    Rodeiro I; Remírez-Figueredo D; García-Mesa M; Dorado P; LLerena A;
    Drug Metabol Drug Interact; 2012; 27(1):57-60. PubMed ID: 22718626
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Paradoxes of evidence in Russian addiction medicine.
    Mendelevich VD; Zalmunin KY
    Int J Risk Saf Med; 2015; 27 Suppl 1():S102-3. PubMed ID: 26639682
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacogenetics in Psychiatry.
    Müller DJ
    Pharmacopsychiatry; 2020 Jul; 53(4):153-154. PubMed ID: 32717764
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Psychiatric pharmacists' perception on the use of pharmacogenomic testing in the mental health population.
    Shishko I; Almeida K; Silvia RJ; Tataronis GR
    Pharmacogenomics; 2015; 16(9):949-58. PubMed ID: 26100610
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systematic evaluation of commercial pharmacogenetic testing in psychiatry: a focus on CYP2D6 and CYP2C19 allele coverage and results reporting.
    Bousman CA; Jaksa P; Pantelis C
    Pharmacogenet Genomics; 2017 Nov; 27(11):387-393. PubMed ID: 28777243
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacogenetics and drug therapy in psychiatry--the role of the CYP2D6 polymorphism.
    Vandel P; Talon JM; Haffen E; Sechter D
    Curr Pharm Des; 2007; 13(2):241-50. PubMed ID: 17269931
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacogenetics and immunosuppressive drugs.
    Hronová K; Šíma M; Světlík S; Matoušková O; Slanař O
    Expert Rev Clin Pharmacol; 2014 Nov; 7(6):821-35. PubMed ID: 25301406
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacogenomics, informatics, and individual drug therapy in psychiatry: past, present and future.
    Preskorn SH
    J Psychopharmacol; 2006 Jul; 20(4 Suppl):85-94. PubMed ID: 16785276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.